Skip to content
FDA drug shortage status

Is Doxycycline Hyclate Tablet, Delayed Release in shortage?

Doxycycline Hyclate Tablet, Delayed Release is listed by FDA as being discontinued by at least one maker (updated Jul 30, 2026).

Being discontinuedFDA status
2packages listed
0unavailable

Every listed package

FDA tracks shortages per package. What each maker reports, most recently updated first:

  • Doxycycline Hyclate, Tablet, Delayed Release, 50 mg (NDC 0591-4550-22)
    Teva Pharmaceuticals USA, Inc.Being discontinuedUpdated Jul 30, 2026Discontinued Jul 30, 2026

    Discontinuation of the manufacture of the drug

    Maker contact: 800-545-8800

  • Doxycycline Hyclate, Tablet, Delayed Release, 200 mg (NDC 0591-4575-60)
    Teva Pharmaceuticals USA, Inc.Being discontinuedUpdated Jul 30, 2026Discontinued Jul 30, 2026

    Discontinuation of the manufacture of the drug

    Maker contact: 800-545-8800

FDA recalls of Doxycycline Hyclate

Recalls can cause or worsen a shortage. These FDA drug recalls share an active ingredient with Doxycycline Hyclate Tablet, Delayed Release:

Doxycycline Hyclate Tablet, Delayed Release shortage questions

Is Doxycycline Hyclate Tablet, Delayed Release in shortage?

Doxycycline Hyclate Tablet, Delayed Release is listed by FDA as being discontinued by at least one maker (updated Jul 30, 2026).

What should I do if I can’t get Doxycycline Hyclate Tablet, Delayed Release?

Don’t stop or ration it on your own. Ask your pharmacist whether another strength, package size or maker is in stock, and ask your prescriber about an alternative if none is.

Source: FDA Drug Shortages Database via openFDA. FDA notes that openFDA data is unvalidated and should not be used to make decisions about medical care; ask your pharmacist or prescriber before changing any medication. FDA Drug Shortages Database.